CIK: 0001465837
Total reported value
—
Reporting period: 2024-12-31 · Number of holdings: 1
Boxer Capital, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2024-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Sold out RVMD
Sold out TYRA
Sold out NUVL
Sold out ONC
Sold out CYTK
Sold out SWTXUSD
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 54% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-12-31 | 1 | — | 0 | |
| 2024-09-30 | 68 | $2.0B | 0 | |
| 2024-06-30 | 61 | $1.9B | 0 | |
| 2024-03-31 | 59 | $2.0B | 0 | |
| 2023-12-31 | 52 | $2.0B | 0 | |
| 2023-09-30 | 73 | $1.9B | 0 | |
| 2023-06-30 | 79 | $2.2B | 0 | |
| 2023-03-31 | 75 | $2.0B | 0 | |
| 2022-12-31 | 71 | $1.9B | 0 | |
| 2022-09-30 | 73 | $1.8B | 0 | |
| 2022-06-30 | 76 | $1.6B | 0 | |
| 2022-03-31 | 74 | $1.9B | 0 | |
| 2021-12-31 | 71 | $2.6B | 0 | |
| 2021-09-30 | 88 | $2.9B | 0 | |
| 2021-06-30 | 95 | $2.8B | 24 | |
| 2021-03-31 | 85 | $2.9B | 36 | |
| 2020-12-31 | 78 | $3.1B | 56 | |
| 2020-09-30 | 75 | $2.9B | 56 | |
| 2020-06-30 | 65 | $2.3B | 54 | |
| 2020-03-31 | 62 | $1.5B | 67 | |
| 2019-12-31 | 51 | $1.8B | 73 | |
| 2019-09-30 | 49 | $1.4B | 100 | |
| 2019-06-30 | 35 | $1.1B | 0 | |
| 2019-03-31 | 23 | $864.7M | 69 | |
| 2018-12-31 | 24 | $809.4M | 50 | |
| 2018-09-30 | 24 | $901.2M | 43 | |
| 2018-06-30 | 26 | $883.1M | 67 | |
| 2018-03-31 | 33 | $936.9M | 63 | |
| 2017-12-31 | 26 | $547.1M | 63 | |
| 2017-09-30 | 30 | $439.3M | 49 | |
| 2017-06-30 | 27 | $420.5M | 45 | |
| 2017-03-31 | 31 | $457.6M | 60 | |
| 2016-12-31 | 28 | $258.5M | 52 | |
| 2016-09-30 | 28 | $223.1M | 86 | |
| 2016-06-30 | 23 | $112.8M | 65 | |
| 2016-03-31 | 22 | $102.2M | 100 | |
| 2015-12-31 | 15 | $115.8M | 0 |
Boxer Capital, LLC's most significant position changes for 2024-12-31: Sold out: Revolution Medicines INC (RVMD); Sold out: Tyra Biosciences INC (TYRA); Sold out: Nuvalent Inc-a (NUVL); Sold out: Beone Medicines Ltd-adr (ONC); Sold out: Cytokinetics INC (CYTK).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | — | EXIT | Sold out |
| 2 | TYRA | Tyra Biosciences INC | — | EXIT | Sold out |
| 3 | NUVL | Nuvalent Inc-a | — | EXIT | Sold out |
| 4 | ONC | Beone Medicines Ltd-adr | — | EXIT | Sold out |
| 5 | CYTK | Cytokinetics INC | — | EXIT | Sold out |
| 6 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 7 | ✓ | Merus N V | — | EXIT | Sold out |
| 8 | SRPT | Sarepta Therapeutics INC | — | EXIT | Sold out |
| 9 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 10 | IDYA | Ideaya Biosciences INC | — | EXIT | Sold out |
| 11 | TNGX | Tango Therapeutics INC | — | EXIT | Sold out |
| 12 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
| 13 | APLSUSD | Apellis Pharmaceuticals INC | — | EXIT | Sold out |
| 14 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 15 | ANAB | Anaptysbio INC | — | EXIT | Sold out |
| 16 | AXSM | Axsome Therapeutics INC | — | EXIT | Sold out |
| 17 | 2662247D | Iteos Therapeutics INC | — | EXIT | Sold out |
| 18 | LEGN | Legend Biotech Corp-adr | — | EXIT | Sold out |
| 19 | GERN | Geron CORP | — | EXIT | Sold out |
| 20 | ✓ | Third Harmonic Bio INC | — | EXIT | Sold out |
| 21 | RCKT | Rocket Pharmaceuticals INC | — | EXIT | Sold out |
| 22 | RCUS | Arcus Biosciences INC | — | EXIT | Sold out |
| 23 | TIL | Instil Bio INC | — | EXIT | Sold out |
| 24 | XENE | Xenon Pharmaceuticals INC | — | EXIT | Sold out |
| 25 | IMVT | Immunovant INC | — | EXIT | Sold out |
| 26 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 27 | SYRE | Spyre Therapeutics INC | — | EXIT | Sold out |
| 28 | KURA | Kura Oncology INC | — | EXIT | Sold out |
| 29 | 4XC1 | Kalvista Pharmaceuticals INC | — | EXIT | Sold out |
| 30 | NKTX | Nkarta INC | — | EXIT | Sold out |
| 31 | ORIC | Oric Pharmaceuticals INC | — | EXIT | Sold out |
| 32 | GPCR | Structure Therapeutics INC | — | EXIT | Sold out |
| 33 | FATE | Fate Therapeutics INC | — | EXIT | Sold out |
| 34 | ELVN | Enliven Therapeutics INC | — | EXIT | Sold out |
| 35 | REPL | Replimune Group INC | — | EXIT | Sold out |
| 36 | DAWNGBX | Day One Biopharmaceuticals I | — | EXIT | Sold out |
| 37 | CGEM | Cullinan Therapeutics INC | — | EXIT | Sold out |
| 38 | ARVN | Arvinas INC | — | EXIT | Sold out |
| 39 | CLYM | Climb Bio INC | — | EXIT | Sold out |
| 40 | RLAY | Relay Therapeutics INC | — | EXIT | Sold out |
| 41 | NRIX | Nurix Therapeutics INC | — | EXIT | Sold out |
| 42 | PRTA | Prothena Corporation plc | — | EXIT | Sold out |
| 43 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 44 | APGE | Apogee Therapeutics INC | — | EXIT | Sold out |
| 45 | OLMA | Olema Pharmaceuticals INC | — | EXIT | Sold out |
| 46 | IOVA | Iovance Biotherapeutics INC | — | EXIT | Sold out |
| 47 | IPSC | Century Therapeutics INC | — | EXIT | Sold out |
| 48 | JSPR | Jasper Therapeutics INC | — | EXIT | Sold out |
| 49 | SANA | Sana Biotechnology INC | — | EXIT | Sold out |
| 50 | 430 | Terns Pharmaceuticals INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-17 | Amendment | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-15 | Amendment | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0000048966
Total reported value
—
1 stks
2024-12-31
Stale — no recent filing
CIK 0000056822
Total reported value
—
1 stks
2019-12-31
Stale — no recent filing
CIK 0000083402
Total reported value
—
1 stks
2021-09-30
Stale — no recent filing